Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Global Polyarticular Juvenile Idiopathic Arthritis Drugs Market - 2022-2029
... growth rate (CAGR) of 6.60% over the forecast period 2022 to 2029. Juvenile idiopathic arthritis (JIA) is one of the most common types of arthritis in kids and teens. Juvenile idiopathic arthritis is a chronic ... Read More
-
Global Warts Therapeutics Market - 2022-2029
... during the forecast period (2022-2029). Warts are skin growth that is caused by the human papillomavirus (HPV). It may persist for years and recurs at the same or different sites, even after treatment. Some factors ... Read More
-
Global Bronchiectasis Treatment Market - 2022-2029
... 6.0% during the forecast period (2022-2029). Bronchiectasis is a condition affecting the airways in the lungs that causes cough, increased mucus production, and recurrent lung infections. The symptoms are caused by abnormal widening of the ... Read More
-
Global Chronic Lymphocytic Leukemia Therapeutics Market - 2022-2029
... a CAGR of 7.90% during the forecast period (2022-2029). Chronic Lymphocytic Leukemia (CLL) is a hematological malignancy marked by excessive proliferation of abnormal white blood cells. CLL predominantly affects the B-cell lymphocytes involved in producing ... Read More
-
Global Castrate Resistant Prostate Cancer Therapeutics Market - 2022-2029
... growing at a CAGR of 8.4% during the forecast period (2022-2029). Castration-resistant prostate cancer is stated as prostate cancer that is scattered to other parts of the body. Several risk factors for castration-resistant prostate cancer ... Read More
-
Global Phenylketonuria Treatment Market - 2022-2029
... accumulates the amino acid phenylalanine. PKU is caused by a mutation in a gene that aids in the production of the phenylalanine-degrading enzyme. Seizures, mental illnesses, and other untreated disorders can result from an excess ... Read More
-
Global Schistosomiasis Drugs Market - 2022-2029
... during the forecast period (2022-2029). Schistosomiasis, also known as Bilharzia, blood fluke, and Katayama fever, is an acute and chronic disease caused by the parasitic worm Schistosoma genus. The disease is spread through waterborne transmission. ... Read More
-
Global Acute Agitation and Aggression Treatment Market - 2022-2029
... excessive verbal or motor behavior in an individual. It can lead to aggression, which can be either verbal or physical. Several treatment options are available for managing acute agitation and aggression, including environmental de-escalation strategies ... Read More
-
Global Gastroesophageal Reflux Disease Therapeutics Market - 2022-2029
... a CAGR of 4 % during the forecast period (2022-2029). GERD is a digestive disorder that occurs when stomach contents such as acid, food, and fluids reflux into the esophagus. It irritates the esophageal lining, ... Read More
-
Global Scleroderma Therapeutics Market - 2022-2029
... 5.98% during the forecast period (2022-2029). Scleroderma therapeutics, or systemic sclerosis, is a chronic connective tissue disease generally classified as one of the autoimmune rheumatic diseases. It causes tissue throughout the body, including the lungs ... Read More
-
Global Dilated Cardiomyopathy Therapeutics Market - 2022-2029
... CAGR of 5.90% during the forecast period (2022-2029). Dilated cardiomyopathy (DCM) is an abnormality of the heart muscle, usually starting in your heart's main pumping chamber (left ventricle). The ventricle becomes weakened and enlarged and ... Read More
-
Global Tourette Syndrome Market - 2022-2029
... involuntary movements and vocalizations called tics. The early symptoms of the disease are typically noticed in childhood, with the average onset age of three and nine years. Tourette syndrome occurs in people from all ethnic ... Read More
-
Global Treprostinil Drugs Market - 2022-2029
... used for the treatment of pulmonary arterial hypertension (PAH), where Treprostinil dilates (widens) the arteries and decreases the amount of blood clotting platelets in the body. These effects lower blood pressure in the pulmonary artery ... Read More
-
Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market - 2022-2029
... CAGR of 5.4% during the forecast period (2022-2029). Non-alcoholic steatohepatitis (NASH) is a common cause of chronic liver disease strongly associated with insulin resistance leading to fibrosis. Type 2 diabetes and NAFLD commonly exist together. ... Read More
-
Global Cancer Treatment Drugs Market - 2022-2029
... of 10.6% during the forecast period (2022-2029). The widespread prevalence of cancer leads to the rapid development of cancer treatment drugs. Various drugs have received regulatory approval from the USFDA (Food and Drug Administration) the ... Read More
-
Global Hunter Syndrome Treatment Market - 2022-2029
... II (MPS II). It is a rare genetic disorder in which large sugar molecules called glycosaminoglycans (or GAGs or mucopolysaccharides) build up in body tissues. It is a form of lysosomal storage disease. If Hunter ... Read More
-
Global Frontotemporal Disorders Treatment Market - 2022-2029
... of 6.50% over the forecast period 2022 to 2029. Frontotemporal disorder, commonly known as Pick disease, is a form of dementia that is caused by a family of brain disorders known as frontotemporal lobar degeneration ... Read More
-
Asthma Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... than 260.6 million diagnosed prevalent cases of Asthma across 16 pharmaceutical markets. GSK is a key player in the disease space with four key products for asthma. Other main players include AstraZeneca, with two products, ... Read More
-
Global Gout Therapeutics Market - 2022-2029
... during the forecast period (2022-2029). Gout is a type of inflammatory arthritis caused by the overabundance of uric acid in the body, either producing too much or excreting too little. Gout can be acute and ... Read More
-
Drugs of Abuse Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
... Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update provides comprehensive information about the Drugs of Abuse pipeline products with comparative analysis of the products at various stages of development and information about ... Read More
-
Global Psoriasis Therapeutics Market Size study & Forecast, by Drug Class (TNF Inhibitors, PDE4 Inhibitors, Interleukin Blockers, and Others), Molecule Type (Biologics, and Small Molecules), and by Route of Administration (Oral, Parenteral, and Topical) and Regional Analysis, 2022-2029
... Regional Analysis, 2022-2029 Global Psoriasis Therapeutics Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Psoriasis ... Read More
-
Global Urinary Tract Cancer Market Size study & Forecast, by Cancer Type (Bladder Cancer, Urethral cancer and Ureteric and Renal Pelvic Cancer), Treatment Type (Chemotherapy, and Immunotherapy), and Distribution Channel (Retail Pharmacy, and Online Pharmacy) and Regional Analysis, 2022-2029
... and Regional Analysis, 2022-2029 Global Urinary Tract Cancer Market is valued approximately USD 2.02 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 18.6% over the forecast period ... Read More
-
Global Kidney Fibrosis Treatment Market Size study & Forecast, by Therapeutics (Angiotensin II receptor blockers (ARBs), Angiotensin Converting Enzyme (ACE) inhibitors, Pirfenidone, Renin Inhibitors, Vasopeptidase Inhibitors), by End User (hospital, Clinics, Home Treatment) and Regional Analysis, 2022-2029
... Analysis, 2022-2029 Global Kidney Fibrosis Treatment Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Kidney ... Read More
-
Global Metabolomics Market - 2022-2029
... forecast period (2022-2029). In metabolomics, biological metabolites are identified and quantified using sophisticated analytical techniques, and information is extracted and interpreted using statistical and multivariate approaches. LC-MS/MS, GC-MS, and/or NMR are some of the complimentary ... Read More
-
Global Chronic Kidney Disease Drugs Market - 2022-2029
... at a CAGR of 6.58% during the forecast period (2022-2029). Chronic kidney disease, also known as chronic kidney failure, describes the gradual loss of kidney function. Kidneys filter the wastes and excess fluids from blood, ... Read More
Research Assistance
